FDA Inspection 773806 — Vitalant

Vitalant — FEI 2275064

The FDA completed an inspection of Vitalant on Mar 14, 2012 in Montvale, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 14, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Montvale, NJ (United States)

Citations

IDCFRDescription
15421 CFR 606.160(a)(1)Concurrent documentation
3121 CFR 606.20(b)Qualifications of responsible personnel
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
8321 CFR 606.100(b)(4)Relate products to the donor
9821 CFR 606.100(c)Thorough investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.